Test Your Knowledge About SOCRA

Reviewed by Editorial Team
The ProProfs editorial team is comprised of experienced subject matter experts. They've collectively created over 10,000 quizzes and lessons, serving over 100 million users. Our team includes in-house content moderators and subject matter experts, as well as a global network of rigorously trained contributors. All adhere to our comprehensive editorial guidelines, ensuring the delivery of high-quality content.
Learn about Our Editorial Process
| By Bseko
B
Bseko
Community Contributor
Quizzes Created: 1 | Total Attempts: 3,377
| Attempts: 3,377 | Questions: 62
Please wait...
Question 1 / 62
0 %
0/100
Score 0/100
1. What is the minimum number of IRB members?

Explanation

The minimum number of IRB members is 5. This is because the IRB (Institutional Review Board) is responsible for reviewing and approving research involving human subjects. To ensure a comprehensive and diverse review, a minimum number of members is required. Having at least 5 members allows for a range of perspectives and expertise to be represented, enhancing the quality and fairness of the review process.

Submit
Please wait...
About This Quiz
Test Your Knowledge About SOCRA - Quiz

This quiz assesses knowledge of SOCRA guidelines, focusing on ethical principles, regulatory compliance, and standards in clinical trials. It prepares learners for effective participation and oversight in human... see moresubjects research. see less

2. The objective of the ICH GCP Guideline is to provide a unified standard for the European Union (EU), Japan, and the United States to facilitate the mutual acceptance of clinical data by the regulatory authorities in these jurisdictions.

Explanation

The ICH GCP Guideline aims to establish a common standard for clinical data acceptance among the EU, Japan, and the US regulatory authorities. This unified standard facilitates the mutual recognition and acceptance of clinical data, reducing the need for duplicative studies and streamlining the drug development process. By adhering to this guideline, sponsors can ensure that their clinical trials meet the regulatory requirements of multiple jurisdictions, saving time and resources. Therefore, the statement is true.

Submit
3. The object of GCP is part of the ICH mission statement.

Explanation

The statement is true because the object of GCP (Good Clinical Practice) is indeed part of the ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use) mission statement. GCP is a set of international ethical and scientific quality standards for designing, conducting, recording, and reporting clinical trials involving human subjects. The ICH is a global organization that develops guidelines and standards for the pharmaceutical industry, and ensuring the use of GCP is one of their objectives. Therefore, the statement is correct.

Submit
4. What are the three fundamental ethical principals for human subjects research?

Explanation

The three fundamental ethical principles for human subjects research are respect for persons, beneficence, and justice. Respect for persons refers to treating individuals as autonomous agents and protecting those with diminished autonomy. Beneficence involves maximizing benefits and minimizing risks to participants, ensuring their well-being. Justice entails fair distribution of the costs and benefits of research, avoiding exploitation and considering the needs of vulnerable populations.

Submit
5. When a short form is used for Informed Consent, the witness must sign either the short form or the summary.

Explanation

False - the witness must sign BOTH the short form and the summary

Submit
6. Who monitors the progress of all clinical trial investigations being conducted under its IND?

Explanation

The sponsor is responsible for monitoring the progress of all clinical trial investigations being conducted under its IND. The sponsor is typically a pharmaceutical company or organization that initiates and funds the clinical trial. They have the ultimate responsibility for ensuring the safety and efficacy of the investigational product. This includes monitoring the progress of the trial, ensuring compliance with regulations and protocols, and overseeing the collection and analysis of data. The sponsor also plays a crucial role in reporting adverse events and ensuring the overall integrity of the trial.

Submit
7. The Code of Federal Regulations that applies to Electronic Records; Electronic Signatures is..

Explanation

The Code of Federal Regulations that applies to Electronic Records; Electronic Signatures is 21CFR11. This regulation sets forth the criteria under which electronic records and electronic signatures are considered trustworthy, reliable, and equivalent to paper records and handwritten signatures. It establishes the requirements for the use of electronic records and signatures in FDA-regulated industries, ensuring the integrity, authenticity, and confidentiality of electronic records and signatures.

Submit
8. The Code of Federal Regulations that applies to the Protection of Human Subjects is..

Explanation

The correct answer is 45CFR46. This code refers to the regulations that apply to the Protection of Human Subjects. It outlines the ethical standards and guidelines for conducting research involving human participants. These regulations aim to ensure the safety, rights, and well-being of individuals involved in research studies.

Submit
9. The World Medical Association (WMA) ethical principals for medical research involving human subjects is called....

Explanation

The Declaration of Helsinki is a set of ethical principles for medical research involving human subjects established by the World Medical Association (WMA). It provides guidelines for researchers to ensure the protection of human subjects' rights and welfare during the research process. The Bellmont Report and the National Research Act are both related to ethical guidelines for human subjects research in the United States, but they are not specific to the WMA. The International Research Act does not exist, making it an incorrect option.

Submit
10. The Code of Federal Regulations that applies to Investigational New Drug Applications is..

Explanation

The correct answer is 21CFR312. This is the specific section of the Code of Federal Regulations that applies to Investigational New Drug Applications (INDs). It outlines the requirements and procedures for conducting clinical trials with investigational drugs in humans. This section covers topics such as the submission of INDs, the responsibilities of sponsors and investigators, informed consent, and reporting of adverse events.

Submit
11. What is the FDA form 482 for?

Explanation

FDA form 482 is used for the purpose of issuing a Notice of Inspection. This form is typically used by the U.S. Food and Drug Administration (FDA) to inform regulated establishments that they will be subject to an inspection. The Notice of Inspection provides details about the scope and purpose of the inspection, as well as the date and time it will take place. This form serves as an official notification to the establishment, ensuring that they are aware of the upcoming inspection and can prepare accordingly.

Submit
12. A(n) ___________________ can be any unfavorable and unintended sign )including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product. 

Explanation

An adverse event refers to any negative and unintended sign, symptom, or disease that occurs after the use of a medicinal or investigational product. This can include abnormal laboratory findings as well. The term AE is commonly used as an abbreviation for adverse event.

Submit
13. This form is used for the voluntary reporting of adverse events and product problems

Explanation

The given correct answer is "3500, FDA form 3500". This answer suggests that the form mentioned, which is FDA form 3500, is used for the voluntary reporting of adverse events and product problems. The number "3500" is likely used as a reference to the specific form, while "FDA form 3500" indicates that it is an official form of the Food and Drug Administration (FDA) in the United States.

Submit
14. What is 45CFR46?

Explanation

45CFR46 refers to Title 45 of the Code of Federal Regulations, Section 46, which is a set of regulations established by the U.S. Department of Health and Human Services (HHS). These regulations provide guidelines and protections for human subjects involved in research studies. The HHS is responsible for ensuring that research involving human subjects is conducted ethically and with the utmost consideration for the safety and well-being of the participants. This includes obtaining informed consent, protecting privacy and confidentiality, and minimizing any potential risks to the participants.

Submit
15. The "Doctor's Trial" prompted the Belmont Report.

Explanation

The "Doctor's Trial" refers to the Nuremberg Trials, which were a series of military tribunals held after World War II to prosecute prominent leaders of Nazi Germany. The Belmont Report, on the other hand, was a response to the unethical experiments conducted by the U.S. Public Health Service on African American men in the Tuskegee Study. Therefore, there is no direct connection between the "Doctor's Trial" and the Belmont Report, making the answer false.

Submit
16. Under 21CFR312, this form is the statement of the investigator of a clinical trial

Explanation

Under 21CFR312, the correct form that serves as the statement of the investigator of a clinical trial is 1572. This form is used to document the investigator's commitment to conduct the study in compliance with the applicable regulations and to protect the rights, safety, and welfare of the study participants. It includes information about the investigator's qualifications, the protocol, the investigational product, and any previous or ongoing clinical trials. The completion and submission of form 1572 is a crucial step in ensuring the integrity and ethical conduct of clinical trials.

Submit
17. This form is used for the mandatory reporting of serious adverse events

Explanation

This answer states that the form used for the mandatory reporting of serious adverse events is the 3500A, FDA form 3500A.

Submit
18. A(n) _______________ is a printed, optical or electronic document designed to record all of the protocol required information to be reported to the sponsor on each trial subject.

Explanation

A case report form (CRF) is a document, whether printed, optical or electronic, that is specifically created to collect and record all the necessary information about each trial subject. This information is then reported to the sponsor. The CRF serves as a standardized tool for capturing and documenting data related to the study, ensuring consistency and accuracy in the reporting process.

Submit
19. The international ethical and scientific quality standard for designing, conducting, recording and reporting trials that involve the participation of human subjects is known as...

Explanation

Good Clinical Practice (GCP) is the international ethical and scientific quality standard for designing, conducting, recording, and reporting trials that involve human subjects. GCP ensures that the rights, safety, and well-being of the participants are protected and that the data generated from the trials are reliable and credible. It provides guidelines for the conduct of clinical trials, including the ethical principles that should be followed, the responsibilities of the investigators and sponsors, and the procedures for data collection and analysis. GCP is widely recognized and accepted by regulatory authorities and research organizations worldwide as the gold standard for clinical trial conduct.

Submit
20. What is the FDA form 3455?

Explanation

The FDA form 3455 is the form used for the disclosure of financial interests and agreements of clinical investigators. This form is used to report any financial interests or arrangements that may create a conflict of interest for the clinical investigator. It is important for the FDA to have this information in order to ensure the integrity and impartiality of clinical trials.

Submit
21. What is 21CFR50 Subpart D?

Explanation

21CFR50 Subpart D refers to the additional safeguards that are put in place for children participating in clinical investigations. This subpart outlines specific requirements and protections that must be followed when conducting research involving children. It ensures that children are not subjected to unnecessary risks and that their rights and welfare are protected throughout the study. This includes obtaining informed consent from both the child and their parent or guardian, ensuring the study is scientifically valid and ethical, and monitoring the child's safety and well-being during the research.

Submit
22. The Code of Federal Regulations that applies to Institutional Review Boards is..

Explanation

The correct answer is 21CFR56. This is because 21CFR56 refers to the specific section of the Code of Federal Regulations that applies to Institutional Review Boards (IRBs). IRBs are responsible for reviewing and approving research involving human subjects to ensure ethical standards are met. Therefore, it is important for IRBs to adhere to the regulations outlined in 21CFR56 to protect the rights and welfare of research participants.

Submit
23. 21CFR56.107 Subpart B is IRB Membership.

Explanation

Thats right mofo

Submit
24. What is 45CFR46 Subpart B?

Explanation

45CFR46 Subpart B provides additional protections for pregnant women, human fetuses, and neonates involved in research. This subpart ensures that these vulnerable populations are given special consideration and safeguards in research studies to protect their rights, welfare, and well-being. It includes specific guidelines and requirements for informed consent, risk assessment, and monitoring of research involving pregnant women, human fetuses, and neonates. These additional protections aim to ensure that the potential benefits of the research outweigh any potential risks and that the rights and welfare of these individuals are protected throughout the study.

Submit
25. What is the federal department responsible for helping people of Canada maintain and improve their health?

Explanation

Health Canada is the federal department responsible for helping people of Canada maintain and improve their health. This department is responsible for a wide range of health-related activities, including regulating and ensuring the safety of food, drugs, and medical devices, promoting healthy living and disease prevention, and providing health information and resources to the public. Health Canada plays a crucial role in protecting and promoting the health and well-being of Canadians.

Submit
26. What is 21CFR50.56 Subpart D?

Explanation

21CFR50.56 Subpart D refers to the requirements for permission by parents or guardians and for assent by children. It specifically pertains to clinical investigations involving children where there may be greater than minimal risk and no prospect of direct benefit to the individual subjects, but likely to yield generalizable knowledge about the subjects' disorder or condition. The term "wards" is used to describe children who are under the legal guardianship of someone else, such as a foster parent or legal guardian.

Submit
27. What is a person or an organization (commercial, academic, or other) contracted by the sponsor of a clinical trial to perform one or more trial-related duty and function?

Explanation

A person or organization contracted by the sponsor of a clinical trial to perform trial-related duties and functions is referred to as a CRO, which stands for Contracted Research Organization. The CRO is responsible for various tasks such as conducting the trial, recruiting participants, collecting and analyzing data, and ensuring compliance with regulatory requirements. They play a crucial role in the successful execution of clinical trials by providing expertise and resources to support the sponsor's research objectives.

Submit
28. The IRB may, for some or all subjects, waive the requirement hat the subject, or the subject's legally authroized representative, sign a written consent form if it finds that the research presents more than minimal risk of harm to subjects and involves no procedures for which written consent is normall required outside the research context.

Explanation

The IRB may, for some or all subjects, waive the requirement hat the subject, or the subject's legally authroized representative, sign a written consent form if it finds that the research presents NO more than minimal risk. The IRB may not do this for research that is more than minimal risk.

Submit
29. What does 21CFR54 deal with?

Explanation

21CFR54 deals with the financial disclosure of clinical investigators. This means that it focuses on the requirements and regulations regarding the disclosure of financial interests and relationships of clinical investigators involved in research studies. This is important to ensure transparency and prevent any potential conflicts of interest that could bias the results or compromise the integrity of the research.

Submit
30. What is the FDA form 3454?

Explanation

FDA form 3454 is the Certification - Financial Interests and Arrangements of Clinical Investigators. This form is used to disclose any financial interests or arrangements that clinical investigators may have that could potentially create a conflict of interest. It is important for the FDA to be aware of any potential conflicts of interest to ensure the integrity and impartiality of the clinical investigation process. By completing this form, clinical investigators are certifying that they have disclosed all relevant financial interests and arrangements.

Submit
31. A(n) _______________ is an investigational or marketed product, or placebo, used as a reference in a clinical trial.

Explanation

In a clinical trial, a comparator is a reference product or placebo that is used to compare the effectiveness and safety of an investigational or marketed product. It serves as a standard against which the new product is measured, allowing researchers to determine if the new product provides any additional benefits or improvements compared to the comparator. This helps in evaluating the efficacy and safety of the new product and making informed decisions about its use in medical practice.

Submit
32. A significant risk device....

Explanation

The correct answer is a combination of all three options. A significant risk device is one that is intended as an implant and presents a potential for serious risk to health, safety, or the well-being of the subject. It is also purported or represented to be for a use in supporting or sustaining human life, which also presents a potential risk to health, safety, or well-being. Additionally, it is used for the substantial importance of diagnosing, curing, mitigating, or treating disease or otherwise preventing impairment of human health, which again presents potential risk to health, safety, or well-being.

Submit
33. ________________ is permission to examine, analyze, verify, and reproduce any records and reports that are important to evaluation of a clinical trial.

Explanation

Direct access refers to the permission granted to individuals or organizations to have unrestricted and immediate access to examine, analyze, verify, and reproduce any records and reports that are crucial for evaluating a clinical trial. This access allows for a comprehensive evaluation of the trial's processes, data, and outcomes, ensuring transparency and accuracy in the evaluation process.

Submit
34. Which of the following is IRB Functions and Regulations?

Explanation

The correct answer is 21CFR56.108 Subpart C. This regulation specifically addresses the functions and operations of Institutional Review Boards (IRBs). It outlines the requirements and responsibilities of IRBs, including the review and approval of research protocols, the informed consent process, and the ongoing monitoring of research studies. Subpart C also covers the composition and membership requirements of IRBs, as well as the procedures for conducting IRB meetings and maintaining records.

Submit
35. What is 21CFR50.52 Subpart D?

Explanation

21CFR50.52 Subpart D refers to a specific section of the Code of Federal Regulations (CFR) that pertains to clinical investigations involving children. The correct answer states that it pertains to clinical investigations involving greater than minimal risk but presenting the prospect of direct benefit to individual subjects - children. This means that the regulations outlined in this subpart apply to studies conducted on children where there is a possibility of potential harm, but also a potential for direct benefit to the individual child participating in the study.

Submit
36. What is 21CFR50.53 Subpart D?

Explanation

21CFR50.53 Subpart D refers to clinical investigations involving greater than minimal risk and no prospect of direct benefit to individual subjects, but likely to yield generalizable knowledge about the subjects' disorder or condition in children. This means that the clinical investigations being conducted on children carry a higher level of risk, but there is no immediate benefit for the individual subjects. However, the information gathered from these investigations is expected to contribute to a better understanding of the disorder or condition being studied in children.

Submit
37. What is 45CFR46 Subpart A?

Explanation

The correct answer is "Basic HHS policy for Protection of Human Research Subjects." 45CFR46 Subpart A refers to the basic policy of the Department of Health and Human Services (HHS) for the protection of human subjects in research. This policy outlines the ethical principles and guidelines that researchers must follow when conducting research involving human subjects. It ensures the protection of participants' rights, welfare, and well-being during the research process.

Submit
38. What is 21CFR50.20 Subpart B?

Explanation

21CFR50.20 Subpart B refers to the section of the Code of Federal Regulations that outlines the general requirements for informed consent in research studies. This subpart specifies the necessary elements and information that must be provided to participants before they can give their informed consent to participate in a study. It ensures that participants are fully aware of the purpose, risks, benefits, and alternatives of the study before making a decision to participate. This subpart also emphasizes the importance of voluntary participation and the right of participants to withdraw from the study at any time.

Submit
39. What is 21CFR50.25 Subpart B?

Explanation

21CFR50.25 Subpart B refers to the section of the Code of Federal Regulations that outlines the elements of informed consent in clinical trials. This includes the information that must be provided to participants, such as the purpose of the study, potential risks and benefits, alternative treatments, and the voluntary nature of participation. It also specifies that informed consent must be obtained in writing and that the participant should have the opportunity to ask questions and have them answered satisfactorily. This regulation ensures that participants are fully informed and able to make an educated decision about their participation in clinical trials.

Submit
40. What is 21CFR50.55 Subpart D?

Explanation

21CFR50.55 Subpart D refers to the requirements for permission by parents or guardians and for assent by children in clinical investigations. This means that when conducting clinical investigations that involve children, the parents or guardians must give their permission for the child to participate, and the child must also provide their assent or agreement to participate. This ensures that the rights and well-being of children are protected in research studies.

Submit
41. What is 21CFR50.50 Subpart D?

Explanation

21CFR50.50 Subpart D refers to the section of the Code of Federal Regulations that outlines the specific duties and responsibilities of an Institutional Review Board (IRB). This section provides guidelines and requirements for IRBs in order to protect the rights and welfare of human subjects involved in research studies. It includes duties such as reviewing and approving research protocols, ensuring informed consent is obtained, monitoring ongoing studies, and ensuring compliance with ethical standards and regulations.

Submit
42. When a short form is used for Informed Consent, the patient signs the short form ONLY and the receives a copy of both the summary and the short form.

Explanation



True. When a short form is used for informed consent, the patient typically signs only the short form, indicating their consent to participate in the study. However, they should also receive a copy of both the short form and the summary of the study, ensuring that they have access to the necessary information about the study before making their decision.
Submit
43. What is 21CFR50.24 subpart B?

Explanation

21CFR50.24 subpart B refers to the exception from informed consent requirements for emergency research. This means that in certain situations where obtaining informed consent from participants is not feasible due to the nature of the emergency, such as in life-threatening situations, the research can be conducted without obtaining consent. This exception allows researchers to proceed with urgent studies that aim to save lives or improve health outcomes without the delay of obtaining informed consent.

Submit
44. 21CFR56 is IRB Functions and Operations.

Explanation

21 CFR 56 is a section of the Code of Federal Regulations (CFR) in the United States that specifically addresses Institutional Review Boards (IRBs). This section outlines the functions and operations of IRBs, including their responsibilities for protecting the rights and welfare of human subjects in research. It provides guidelines for IRB membership, review procedures, record keeping, and other aspects of IRB management.

Submit
45. What is 21CFR56.110 Subpart C?

Explanation

Expedited review procedures for certain kinds of research involving no more than minimal risk for minor changes in approved research refers to the process by which an Institutional Review Board (IRB) can review and approve research studies that involve minimal risk and minor changes to previously approved research protocols. This allows for a more streamlined and efficient review process for studies that pose minimal risk to participants and require only minor modifications to the original research plan.

Submit
46. What do the HHS stand for?

Explanation



HHS, which stands for "Health and Human Services," denotes the U.S. Department of Health and Human Services. This federal agency strives to enhance the well-being of all Americans by offering a range of health-related initiatives and programs aimed at fostering improved health and providing essential human services.
Submit
47. What is 45CFR46 Subpart C?

Explanation

45 CFR 46 is a section of the Code of Federal Regulations (CFR) in the United States that provides regulations for the protection of human subjects in research. Subpart C of 45 CFR 46 specifically addresses additional protections for prisoners involved in research. This subpart outlines specific requirements for IRB review, informed consent, and research design when conducting research with prisoners. It aims to ensure that prisoners are not coerced or unduly influenced to participate in research and that their rights and welfare are protected.

Submit
48. What is 21CFR50 Subpart B?

Explanation

21CFR50 Subpart B refers to the regulations that outline the protection of human subjects in clinical investigations. These regulations ensure that individuals participating in clinical trials are treated ethically and their rights and well-being are safeguarded. The regulations cover aspects such as informed consent, assessment of risks and benefits, and the responsibilities of Institutional Review Boards (IRBs) in reviewing and approving research protocols. This subpart is crucial in maintaining the ethical conduct of clinical investigations and ensuring the safety and welfare of human subjects involved.

Submit
49. What is 21CFR50.27 Subpart B?

Explanation

21CFR50.27 Subpart B refers to the section of the US Code of Federal Regulations that pertains to the documentation of informed consent in research studies. This means that it outlines the specific requirements and guidelines for documenting the process of obtaining informed consent from participants in research studies. It likely includes information on what should be included in the consent form, how it should be presented to participants, and how the consent process should be documented and maintained.

Submit
50. The form _____________ is used for investigational new drugs (or IND).

Explanation

not-available-via-ai

Submit
51. 21CFR56 Subpart B is IRB Documentation.

Explanation

21CFR56 Subpart B is Organization and Personnel

Submit
52. What is 21CFR50.51 Subpart D?

Explanation

Remember - all sections under subpart D of 21CFR50 deal with children - the heading for all of subpart D is Additional Safeguards for Children in Clinical Investigations

Submit
53. Which of the following is 21CFR56.106 Subpart B?

Explanation

Subpart B of 21CFR56.106 refers to IRB Membership. This section outlines the requirements and qualifications for individuals who serve as members of an Institutional Review Board (IRB). It specifies the necessary expertise and diversity that should be present within the IRB membership to ensure the protection of human subjects in clinical trials. The registration and IRB functions and operations are covered in other subparts of 21CFR56.106.

Submit
54. In the pre-approval clinical experience with a new medicinal product or its new usages, particularly as the therapuyetic dose(s) may not be established: all noxious and unintended responses to a medicinal product related to any dose should be considered __________________.

Explanation

In the pre-approval clinical experience with a new medicinal product or its new usages, all noxious and unintended responses to the medicinal product related to any dose should be considered as adverse drug reactions (ADRs). This means that any negative or unintended effects that occur as a result of taking the medication, regardless of the dose, should be taken into account and reported as ADRs. This is important because it helps to gather information about the safety profile of the medication and identify any potential risks or side effects.

Submit
55. What is 21CFR50.54 Subpart D?

Explanation

21CFR50.54 Subpart D refers to clinical investigations that are not otherwise approvable but provide an opportunity to understand, prevent, or alleviate a serious problem affecting the health or welfare of children. This means that even though these investigations may not meet the usual approval criteria, they are allowed because they address a significant issue related to children's health and well-being. The focus is on finding solutions or improving the situation for children who are facing serious health problems.

Submit
56. What is 21CFR50.23 Subpart B?

Explanation

21CFR50.23 Subpart B refers to the exception from general requirements for informed consent. In certain situations, such as when obtaining informed consent is not feasible or would compromise the validity of the research, this exception allows researchers to conduct studies without obtaining informed consent from the participants. This exception is typically applied in emergency research situations where immediate intervention is required and obtaining consent would delay or hinder the research process.

Submit
57. What is 21CFR56.109 Subpart C?

Explanation

21CFR56.109 Subpart C refers to the specific section of the Code of Federal Regulations (CFR) that outlines the requirements for Institutional Review Boards (IRBs) in reviewing research studies. This subpart provides guidelines and regulations for the IRB's evaluation of research protocols, informed consent processes, and the protection of human subjects involved in the research. It ensures that the IRB thoroughly reviews and approves research studies to ensure the ethical and safe conduct of the research.

Submit
58. The FDA form 483 is used for ...

Explanation

The FDA form 483 is used for documenting inspectional observations made during an inspection of a regulated facility. It is a tool used by the FDA to communicate to the facility the observations made during the inspection, which may include deviations from regulations or non-compliance with good manufacturing practices. The form allows the FDA to inform the facility of the issues found and gives the facility an opportunity to respond and provide corrective actions.

Submit
59. Providing a unified standard for Europe, US, and Japan to facilitate the acceptance of clinical trials is the...

Explanation

The GCP Guidelines aim to provide a unified standard for Europe, US, and Japan in order to facilitate the acceptance of clinical trials. This means that the guidelines outline the requirements and best practices that should be followed in conducting clinical trials in these regions, ensuring that the trials are conducted ethically, with participant safety as a priority, and with reliable and valid results. The mission statement of the GCP Guidelines reflects their purpose and goals in harmonizing clinical trial practices across different countries.

Submit
60. Which of the following are considered BASIC elements of informed consent under section 21CFR50.25 Subpart B?

Explanation

The given answer includes the basic elements of informed consent under section 21CFR50.25 Subpart B. These elements include: a statement that the study involves research, an explanation of the purposes of the research and the expected duration of the subject's participation, a description of the procedures to be followed, and identification of any procedures which are experimental; a description of any reasonably foreseeable risks or discomforts to the subject; a description of any benefits to the subject or to others which may reasonably be expected from the research; a disclosure of appropriate alternative procedures or courses of treatment, if any, that might be advantageous to the subject; a statement describing the extent, if any, to which confidentiality of records identifying the subject will be maintained and noting the possibility of FDA inspection; for research involving more than minimal risk, an explanation of compensation and availability of medical treatments in case of injury; an explanation of whom to contact for questions about the research and research subjects' rights, and in case of research-related injury; and a statement that participation is voluntary without penalty or loss of benefits.

Submit
61. Which of the following are necessary to satisfy 21CFR50.23 Subpart B?

Explanation

The necessary conditions to satisfy 21CFR50.23 Subpart B include: the absence of alternative therapies with a higher likelihood of saving the subject's life, insufficient time to obtain consent from the subject's legal representative, inability to obtain informed consent from the subject due to communication barriers or legal constraints, and the presence of a life-threatening situation that requires the use of the test article.

Submit
62. Which of the following are necessary to satisy 21CFR50.24 Subpart B?

Explanation

Oompa Loompas don't even exist silly

Submit
View My Results

Quiz Review Timeline (Updated): Nov 4, 2024 +

Our quizzes are rigorously reviewed, monitored and continuously updated by our expert board to maintain accuracy, relevance, and timeliness.

  • Current Version
  • Nov 04, 2024
    Quiz Edited by
    ProProfs Editorial Team
  • Sep 21, 2017
    Quiz Created by
    Bseko
Cancel
  • All
    All (62)
  • Unanswered
    Unanswered ()
  • Answered
    Answered ()
What is the minimum number of IRB members?
The objective of the ICH GCP Guideline is to provide a unified...
The object of GCP is part of the ICH mission statement.
What are the three fundamental ethical principals for human subjects...
When a short form is used for Informed Consent, the witness must sign...
Who monitors the progress of all clinical trial investigations being...
The Code of Federal Regulations that applies to Electronic Records;...
The Code of Federal Regulations that applies to the Protection of...
The World Medical Association (WMA) ethical principals for medical...
The Code of Federal Regulations that applies to Investigational New...
What is the FDA form 482 for?
A(n) ___________________ can be any unfavorable and unintended sign...
This form is used for the voluntary reporting of adverse events and...
What is 45CFR46?
The "Doctor's Trial" prompted the Belmont Report.
Under 21CFR312, this form is the statement of the investigator of a...
This form is used for the mandatory reporting of serious adverse...
A(n) _______________ is a printed, optical or electronic document...
The international ethical and scientific quality standard for...
What is the FDA form 3455?
What is 21CFR50 Subpart D?
The Code of Federal Regulations that applies to Institutional Review...
21CFR56.107 Subpart B is IRB Membership.
What is 45CFR46 Subpart B?
What is the federal department responsible for helping people of...
What is 21CFR50.56 Subpart D?
What is a person or an organization (commercial, academic, or other)...
The IRB may, for some or all subjects, waive the requirement hat the...
What does 21CFR54 deal with?
What is the FDA form 3454?
A(n) _______________ is an investigational or marketed product, or...
A significant risk device....
________________ is permission to examine, analyze, verify, and...
Which of the following is IRB Functions and Regulations?
What is 21CFR50.52 Subpart D?
What is 21CFR50.53 Subpart D?
What is 45CFR46 Subpart A?
What is 21CFR50.20 Subpart B?
What is 21CFR50.25 Subpart B?
What is 21CFR50.55 Subpart D?
What is 21CFR50.50 Subpart D?
When a short form is used for Informed Consent, the patient signs the...
What is 21CFR50.24 subpart B?
21CFR56 is IRB Functions and Operations.
What is 21CFR56.110 Subpart C?
What do the HHS stand for?
What is 45CFR46 Subpart C?
What is 21CFR50 Subpart B?
What is 21CFR50.27 Subpart B?
The form _____________ is used for investigational new drugs (or IND).
21CFR56 Subpart B is IRB Documentation.
What is 21CFR50.51 Subpart D?
Which of the following is 21CFR56.106 Subpart B?
In the pre-approval clinical experience with a new medicinal product...
What is 21CFR50.54 Subpart D?
What is 21CFR50.23 Subpart B?
What is 21CFR56.109 Subpart C?
The FDA form 483 is used for ...
Providing a unified standard for Europe, US, and Japan to facilitate...
Which of the following are considered BASIC elements of informed...
Which of the following are necessary to satisfy 21CFR50.23 Subpart B?
Which of the following are necessary to satisy 21CFR50.24 Subpart B?
Alert!

Advertisement